First United Bank & Trust’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$550K Buy
2,187
+32
+1% +$6.88K 0.16% 102
2026
Q1
$469K Sell
2,155
-30
-1% -$6.66K 0.15% 104
2025
Q4
$499K Sell
2,185
-910
-29% -$207K 0.16% 109
2025
Q3
$717K Hold
3,095
0.23% 86
2025
Q2
$574K Hold
3,095
0.2% 91
2025
Q1
$648K Sell
3,095
-15
-0.5% -$2.92K 0.24% 79
2024
Q4
$553K Sell
3,110
-24
-0.8% -$4.41K 0.2% 93
2024
Q3
$619K Sell
3,134
-57
-2% -$10.6K 0.22% 88
2024
Q2
$547K Hold
3,191
0.2% 97
2024
Q1
$581K Sell
3,191
-156
-5% -$26.9K 0.22% 94
2023
Q4
$519K Buy
3,347
+470
+16% +$68.5K 0.21% 99
2023
Q3
$429K Sell
2,877
-165
-5% -$24.2K 0.2% 105
2023
Q2
$410K Buy
3,042
+36
+1% +$5.28K 0.18% 109
2023
Q1
$479K Hold
3,006
0.22% 99
2022
Q4
$486K Sell
3,006
-42
-1% -$6.44K 0.24% 96
2022
Q3
$409K Hold
3,048
0.21% 104
2022
Q2
$467K Buy
3,048
+1,340
+78% +$205K 0.21% 101
2022
Q1
$277K Sell
1,708
-308
-15% -$44.7K 0.11% 139
2021
Q4
$273K Hold
2,016
0.1% 148
2021
Q3
$217K Sell
2,016
-435
-18% -$49.7K 0.09% 156
2021
Q2
$276K Sell
2,451
-180
-7% -$20.3K 0.12% 137
2021
Q1
$285K Hold
2,631
0.12% 130
2020
Q4
$282K Hold
2,631
0.14% 114
2020
Q3
$230K Hold
2,631
0.13% 114
2020
Q2
$258K Hold
2,631
0.15% 104
2020
Q1
$200K Hold
2,631
0.14% 109
2019
Q4
$233K Buy
+2,631
New +$218K 0.13% 121
2019
Q1
Sell
-2,407
Closed -$222K 116
2018
Q4
$222K Sell
2,407
-87
-3% -$7.65K 0.16% 111
2018
Q3
$236K Sell
2,494
-50
-2% -$4.74K 0.15% 110
2018
Q2
$236K Sell
2,544
-14
-0.5% -$1.37K 0.16% 104
2018
Q1
$242K Buy
2,558
+47
+2% +$5.16K 0.16% 101
2017
Q4
$243K Hold
2,511
0.16% 102
2017
Q3
$223K Buy
+2,511
New +$191K 0.15% 102
2016
Q4
Sell
-3,167
Closed -$200K 107
2016
Q3
$200K Buy
+3,167
New +$205K 0.17% 98

Other funds holding ABBV

First United Bank & Trust's ABBV Position: Q2 2026 in Review

First United Bank & Trust increased its AbbVie (ABBV) stake by 1.5% in Q2 2026, buying an estimated $6.88K and bringing the position to 2,187 shares worth $550K. The position accounts for 0.16% of the portfolio, ranked #102.

First United Bank & Trust first reported a position in ABBV in Q3 2016 and has held it in 34 quarters since. The position peaked at $717K in Q3 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • First United Bank & Trust held 2,187 shares of AbbVie worth $550K as of Q2 2026.
  • First United Bank & Trust bought 32 AbbVie shares in Q2 2026, an estimated $6.88K.
  • AbbVie made up 0.16% of First United Bank & Trust's portfolio in Q2 2026, its #102 holding.
  • First United Bank & Trust first reported a position in AbbVie in Q3 2016 and has held it in 34 quarters since.
  • First United Bank & Trust's AbbVie position peaked at $717K in Q3 2025.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on First United Bank & Trust's 13F filing for Q2 2026, filed 20 Jul 2026.